- Home
- ANIP vs ARR Comparison
ANIP vs ARR Comparison
Compare ANIP & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- ARR
- Stock Information
- Founded
- ANIP 2001
- ARR 2008
- Country
- ANIP United States
- ARR United States
- Employees
- ANIP N/A
- ARR N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- ARR Real Estate Investment Trusts
- Sector
- ANIP Health Care
- ARR Real Estate
- Exchange
- ANIP Nasdaq
- ARR Nasdaq
- Market Cap
- ANIP 2.0B
- ARR 1.8B
- IPO Year
- ANIP N/A
- ARR N/A
- Fundamental
- Price
- ANIP $91.65
- ARR $15.89
- Analyst Decision
- ANIP Strong Buy
- ARR Buy
- Analyst Count
- ANIP 8
- ARR 4
- Target Price
- ANIP $93.63
- ARR $15.50
- AVG Volume (30 Days)
- ANIP 318.4K
- ARR 3.5M
- Earning Date
- ANIP 11-07-2025
- ARR 10-22-2025
- Dividend Yield
- ANIP N/A
- ARR 18.13%
- EPS Growth
- ANIP N/A
- ARR N/A
- EPS
- ANIP N/A
- ARR N/A
- Revenue
- ANIP $747,399,000.00
- ARR $20,589,000.00
- Revenue This Year
- ANIP $39.36
- ARR $350.86
- Revenue Next Year
- ANIP $9.45
- ARR $54.46
- P/E Ratio
- ANIP N/A
- ARR N/A
- Revenue Growth
- ANIP 38.68
- ARR N/A
- 52 Week Low
- ANIP $52.50
- ARR $13.18
- 52 Week High
- ANIP $99.50
- ARR $20.39
- Technical
- Relative Strength Index (RSI)
- ANIP 46.26
- ARR 62.43
- Support Level
- ANIP $88.19
- ARR $14.00
- Resistance Level
- ANIP $92.52
- ARR $15.73
- Average True Range (ATR)
- ANIP 2.40
- ARR 0.30
- MACD
- ANIP -0.93
- ARR 0.16
- Stochastic Oscillator
- ANIP 26.50
- ARR 98.62
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.